PTJ
IDYA icon

Paul Tudor Jones’s IDEAYA Biosciences IDYA Stock Holding History

Paul Tudor Jones’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
45,287
+2,582
+6% +$79K ﹤0.01% 2061
2026
Q1 		$1.42M Sell
42,705
-5,233
-11% -$176K ﹤0.01% 2111
2025
Q4 		$1.66M Buy
47,938
+10,343
+28% +$330K ﹤0.01% 1945
2025
Q3 		$1.02M Buy
+37,595
New +$909K ﹤0.01% 2254
2023
Q4 		– Sell
-20,931
Closed -$565K – 2591
2023
Q3 		$565K Buy
+20,931
New +$531K 0.01% 1617

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Paul Tudor Jones's IDYA Position: Q2 2026 in Review

Paul Tudor Jones increased its IDEAYA Biosciences (IDYA) stake by 6% in Q2 2026, buying an estimated $79K and bringing the position to 45,287 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

Paul Tudor Jones first reported a position in IDYA in Q3 2023 and has held it in 5 quarters since. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Paul Tudor Jones held 45,287 shares of IDEAYA Biosciences worth $1.69M as of Q2 2026.
  • Paul Tudor Jones bought 2,582 IDEAYA Biosciences shares in Q2 2026, an estimated $79K.
  • IDEAYA Biosciences made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2061 holding.
  • Paul Tudor Jones first reported a position in IDEAYA Biosciences in Q3 2023 and has held it in 5 quarters since.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.